Latest Breaking News On - Professor of rheumatology at bristol medical school - Page 1 : comparemela.com

New research highlights potential safety concerns around women taking romosozumab, a new anti-osteoporosis drug available on the NHS. The University of Bristol-led study, published in Arthritis & Rheumatology, analysed genetic data on nearly 34,0

Jon tobiasBristol medical schoolProfessor of rheumatology at bristol medical schoolUniversity of bristolTranslational health sciencesAvon longitudinal studyEpidemiology unit